Hideo Shigematsu

16PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 17, 2026
De-escalation of perioperative systemic therapy for early breast cancer.

|Jul 01, 2026
De-escalation of breast surgery for early stage breast cancer.

|Jun 10, 2026
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.

|May 16, 2026
Primary tumour resection reduces the risk of major local morbidity in de novo stage IV breast cancer: secondary data analysis from the JCOG1017 randomized clinical trial.

|Mar 19, 2026
Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study.

Norikazu Masuda, Hiroyuki Yasojima, Hiroko Bando

|Jan 30, 2026
A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110).

Keita Sasaki, Toshiyuki Ishiba, Ikuno Nishibuchi

Pageof 3

Frequent Collaborators

5 joint publications

Tadahiko Shien

4 joint publications

Yukinori Ozaki

4 joint publications

Kazuki Sudo

3 joint publications

Toshiyuki Ishiba